ConductScience.org, home

Paper351504

Long-term experience with timolol ophthalmic solution in patients with open-angle glaucoma.

Boger WP and 3 others. Ophthalmology, 1978. Cited by 153 papers, by iCite.

Cite this record

ConductScience Library. Long-term experience with timolol ophthalmic solution in patients with open-angle glaucoma. Papers, record 351504. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/351504

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Long-term experience with timolol ophthalmic solution in patients with open-angle glaucoma.
PubMed
Journal
Ophthalmology
PubMed
Year
1978
PubMed
Publication types
Clinical Trial, Journal Article
PubMed
Citations, by iCite
153
iCite
Relative citation ratio, by iCite
9.55
iCite
Revised in PubMed
2019-07-26
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Boger WP 3rdW P
2Puliafito CAC A
3Steinert RFR F
4Langston DPD P

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
GlaucomaMajor topic
PropanolaminesMajor topic
TimololMajor topic
Adult
Clinical Trials as Topic
Depression, Chemical
Evaluation Studies as Topic
Follow-Up Studies
Humans
Intraocular Pressure
Ophthalmic Solutions
Pulse

Source PubMed

Download CSV of topics

Cited by29

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 153 citations.

PMIDTitleJournalYearIn PapersSource
41466900Five-Year Outcomes of Omidenepag Isopropyl Monotherapy for Untreated Primary Open-Angle Glaucoma.Cureus2025https://conductscience.org/library/papers/41466900PubMed
38082203Adrenoceptors in the Eye - Physiological and Pathophysiological Relevance.Handb Exp Pharmacol2024https://conductscience.org/library/papers/38082203PubMed
32440086Short-Term Efficacy and Safety of Switching from a Latanoprost/Timolol Fixed Combination to a Latanoprost/Carteolol Fixed Combination.Clin Ophthalmol2020https://conductscience.org/library/papers/32440086PubMed
30794789Effect of Timolol on Aqueous Humor Outflow Facility in Healthy Human Eyes.Am J Ophthalmol2019https://conductscience.org/library/papers/30794789PubMed
25061275Efficacy and safety of switching to latanoprost 0.005%-timolol maleate 0.5% fixed-combination eyedrops from an unfixed combination for 36 months.Clin Ophthalmol2014https://conductscience.org/library/papers/25061275PubMed
21681417Effects of brimonidine timolol fixed combination therapy on anterior ocular segment configuration.Jpn J Ophthalmol2011https://conductscience.org/library/papers/21681417PubMed
21052902Effects of brimonidine 0.2%-timolol 0.5% fixed-combination therapy for glaucoma.Jpn J Ophthalmol2010https://conductscience.org/library/papers/21052902PubMed
19668385Managing refractory glaucoma with a fixed combination of bimatoprost (0.03%) and timolol (0.5%).Clin Ophthalmol2008https://conductscience.org/library/papers/19668385PubMed
17041807Topical drug therapy in glaucoma.Wien Med Wochenschr2006https://conductscience.org/library/papers/17041807PubMed
10776828Pharmacological therapy for glaucoma: a review.Drugs2000https://conductscience.org/library/papers/10776828PubMed
10655195
Comparison of the intraocular pressure lowering effect of latanoprost and a fixed combination of timolol-pilocarpine eye drops in patients insufficiently controlled with beta adrenergic antagonists. French Latanoprost Study Group, and the Swedish Latanoprost Study Group.
Br J Ophthalmol2000https://conductscience.org/library/papers/10655195PubMed
7398530Timolol eye drops: bradycardia or tachycardia?Doc Ophthalmol1980https://conductscience.org/library/papers/7398530PubMed
7387959Timolol in operated closed-angle glaucoma.Br J Ophthalmol1980https://conductscience.org/library/papers/7387959PubMed
7363532Absorption of ocular timolol.Clin Pharmacokinet1980https://conductscience.org/library/papers/7363532PubMed
7216626Effects of timolol on corneal sensitivity and tear production.Int Ophthalmol1980https://conductscience.org/library/papers/7216626PubMed
7075965The IOP-lowering effect of timolol in simple and capsular glaucoma. A multicenter study in Finland.Graefes Arch Clin Exp Ophthalmol1982https://conductscience.org/library/papers/7075965PubMed
7039666Dose response of oral timolol combined with adrenaline.Br J Ophthalmol1982https://conductscience.org/library/papers/7039666PubMed
7028085Study of the additive effect of timolol and epinephrine in lowering intraocular pressure.Br J Ophthalmol1981https://conductscience.org/library/papers/7028085PubMed
7004479Interaction of timolol and adrenaline.Br J Ophthalmol1981https://conductscience.org/library/papers/7004479PubMed
6909025Dose-related interaction between timolol and adrenaline.Albrecht Von Graefes Arch Klin Exp Ophthalmol1981https://conductscience.org/library/papers/6909025PubMed

See all 29 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/351504

GET https://conductscience.org/api/papers/v1/351504/cited_by?page=2